Digital Art and Artificial Intelligence
Launched by OLIVIER BEAUCHET · Sep 19, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special digital app that uses beautiful impressionist artworks to help improve the mental well-being of both young and older adults. The app allows users to interact with paintings by artists like Claude Monet and Helen McNicoll, and it even includes music created through artificial intelligence. The aim of the study is to see how easy and enjoyable the app is to use, especially for older adults who might have difficulty with technology or may experience sensory impairments. Researchers want to understand how both age groups use the app, what they think about it, any challenges they face, and what improvements they would like.
To participate in this study, eligible individuals must be adults aged 18 and older, without any psychiatric or cognitive disorders, and able to understand spoken and written French. Participants will have the chance to use the app and share their experiences through interviews and observations. This is a great opportunity for those interested in exploring how art can positively affect mental health, while also helping to shape tools that could benefit others in the future.
Gender
ALL
Eligibility criteria
- 1. For adults of any age:
- 1. Inclusion criteria:
- • Concordance of sex and gender.
- • No psychiatric or cognitive disorders.
- • Ability to understand spoken and written French.
- • Provide written consent to participate in the study.
- 2. Exclusion criteria:
- • Non-binary.
- • Inability to provide informed consent to participate in the study.
- • Participation in a concurrent experimental clinical study to avoid interference with our study.
- • Inability to understand spoken and written French.
- • Having moderate to severe visual or auditory impairment.
- 2. Young adults:
- • The inclusion criterion is being aged between 18 and 35 years.
- 3. Older adults:
- • The inclusion criterion is being aged 60 years or older.
About Olivier Beauchet
Olivier Beauchet is a distinguished clinical trial sponsor known for advancing medical research and innovation. With a focus on enhancing patient outcomes, Beauchet leads a portfolio of clinical studies that span various therapeutic areas. His commitment to rigorous scientific methodologies and ethical standards ensures the integrity and reliability of trial results. By fostering collaborations with healthcare professionals and institutions, Olivier Beauchet aims to drive breakthroughs in treatment options and contribute to the overall advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montreal, Quebec, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported